ALS Group USA, Corp. has tested in the area of racing chemistry for over 70 years, analyzing tens of thousands of biological specimens per year for the presence of performance altering and therapeutic drugs. In addition to testing racing animals (equine and canine), we test for horse and livestock shows and exhibitions. Truesdail uses state-of-the-art instrumentation to provide highly sensitive screening and identification for a vast variety of drug compounds.
Our Drug Testing Laboratory has extensive cross training in each key area including UHPLC/HRMS, LC/MS/MS, GC/MS, ICP/MS, and immunoassay operations. All of our chemists and technicians are thoroughly trained analysts and chain-of-custody protocols.
ALS-Irvine currently performs animal drug testing for many U.S. states – Delaware, Idaho, Maryland, Nebraska, Nevada, New Jersey, Oregon, Washington, and Wyoming — and the countries of Mexico, Panama, and Columbia. Additionally, we provide split-sample testing to almost every racing jurisdiction in the U.S. and several foreign countries. The U.S. map below color-delineates the states where ALS-Irvine has, or is currently, conducting testing.
Our procedures are reviewed and accepted under our accreditations for ISO/IEC 17025, ILAC G-7, and RMTC. Since 2009, ALS is fully accredited to ISO/IEC 17025 for all parameters required by drug testing programs. In 2013 Truesdail was the first lab in the U.S. to add Cobalt analysis onto our ISO/IEC 17025 scope. In 2014 ALS-Irvine was one of the first five U.S. labs to receive accreditation from Racing Medication and Testing Consortium (RMTC). Our Technical Services Manager, Dr. Anthony Fontana serves on the RMTC’s Scientific Advisory Committee.
Our staff’s experience in drug testing, coupled with our forensic science expertise, enables us to give “expert witness” testimony at hearings and in court cases. We have done so in dozens of cases in Arkansas, California, Kentucky, New Jersey, Oregon, and Indiana.